Exane BNP Paribas analyst Sami Kassab downgrades Thomson Reuters (NYSE:TRI) from Neutral to Underperform.
MAIA Biotechnology Announces 170,940 Share Purchase By Director Adelina Louie In Private Placement
Five independent members of MAIA's Board of Directors purchased shares in the offeringMAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted
